[1]
Mishra, R. and Dhole, S. 2017. DIPEPTIDYL PEPTIDASE-4 INHIBITORS: POTENTIAL FOR TREATMENT OF METABOLIC SYNDROME AND DEVELOPED FORMULATION APPROACHES. Asian Journal of Pharmaceutical and Clinical Research. 10, 11 (Nov. 2017), 20–26. DOI:https://doi.org/10.22159/ajpcr.2017.v10i11.20342.